Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson

Last Updated: December 11, 2019

DrugPatentWatch Database Preview

Ethinyl estradiol; etonogestrel - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What are the generic drug sources for ethinyl estradiol; etonogestrel and what is the scope of patent protection?

Ethinyl estradiol; etonogestrel is the generic ingredient in one branded drug marketed by Organon Sub Merck and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are twenty-six drug master file entries for ethinyl estradiol; etonogestrel. Three suppliers are listed for this compound.

Recent Clinical Trials for ethinyl estradiol; etonogestrel

Identify potential brand extensions & 505(b)(2) entrants

University of Sao PauloPhase 4
Merck Sharp & Dohme Corp.Phase 3
Merck Sharp & Dohme Corp.Phase 4

See all ethinyl estradiol; etonogestrel clinical trials

Recent Litigation for ethinyl estradiol; etonogestrel

Identify potential future generic entrants

District Court Litigation
Case NameDate
Merck Sharp & Dohme B v. v. Dr. Reddy's Laboratories, S.A.2015-09-11
Merck Sharp & Dohme B v. v. Warner Chilcott Company LLC2013-12-24

See all ethinyl estradiol; etonogestrel litigation

Pharmacology for ethinyl estradiol; etonogestrel
Paragraph IV (Patent) Challenges for ETHINYL ESTRADIOL; ETONOGESTREL
Tradename Dosage Ingredient NDA Submissiondate
NUVARING RING;VAGINAL ethinyl estradiol; etonogestrel 021187 2013-06-17

US Patents and Regulatory Information for ethinyl estradiol; etonogestrel

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Organon Sub Merck NUVARING ethinyl estradiol; etonogestrel RING;VAGINAL 021187-001 Oct 3, 2001 RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.